BMC BioinformaticsBioinformaticsPeer-reviewed journal article
Frugal alignment-free identification of FLT3-internal tandem duplications with FiLT3r
Augustin BoudryiD, Sasha DarmoniD, Nicolas DuployeziD, Martin FigeaciD, Sandrine Geffroy, Maxime Bucci, Karine Celli‐LebrasiD, Matthieu DuchmanniD, Romane JoudinaudiD, Laurène FenwarthiD, Olivier NiboureliD, Laure GoursaudiD, Raphaël ItzyksoniD, Hervé DombretiD, Mathilde HunaultiD, Claude PreudhommeiD, Mikaël SalsoniD
Abstract
BackgroundInternal tandem duplications in the FLT3 gene, termed FLT3-ITDs, are useful molecular markers in acute myeloid leukemia (AML) for patient risk stratification and follow-up. FLT3-ITDs are increasingly screened through high-throughput sequencing (HTS) raising the need for robust and efficient algorithms. We developed a new algorithm, which performs no alignment and uses little resources, to identify and quantify FLT3-ITDs in HTS data. ResultsOur algorithm (FiLT3r) focuses on the k-mers from reads covering FLT3 exons 14 and 15. We show that those k-mers bring enough information to accurately detect, determine the length and quantify FLT3-ITD duplications. We compare the performances of FiLT3r to state-of-the-art alternatives and to fragment analysis, the gold standard method, on a cohort of 185 AML patients sequenced with capture-based HTS. On this dataset FiLT3r is more precise (no false positive nor false negative) than the other software evaluated. We also assess the software on public RNA-Seq data, which confirms the previous results and shows that FiLT3r requires little resources compared to other software. ConclusionFiLT3r is a free software available at https://gitlab.univ-lille.fr/filt3r/filt3r. The repository also contains a Snakefile to reproduce our experiments. We show that FiLT3r detects FLT3-ITDs better than other software while using less memory and time.
- organism: human
- assay: whole-exome sequencing
- research focus: variant calling
- approach: statistical model
- Citations
- 25
- FWCI
- 3.82
- Field percentile
- top 5%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Classes of ITD predict outcomes in patients with AML treated with FLT3 inhibitors
G. W. Schwartz, B. Manning, … R. Faryabi·bioRxiv·May 14, 2018
- A key role of the WEE1-CDK1 axis in mediating TKI-therapy resistance in FLT3-ITD positive acute myeloid leukemia patients
G. Massacci, V. Venafra, … F. Sacco·bioRxiv·May 16, 2022
- Twenty novel nsSNPs may affect FLT3 gene leading to Acute Myeloid Leukemia (AML) using in silico analysis
Tarig Alsheikh, Tebyan Ameer, … Mohammed A. Hassan·bioRxiv·Jun 24, 2023
- Unveiling the signaling network of FLT3-ITD AML improves drug sensitivity prediction
S. Latini, V. Venafra, … F. Sacco·bioRxiv·Jun 22, 2023
- High-throughput identification of FLT3 wild-type and mutant kinase substrate preferences and application to design of sensitive in vitro kinase assay substrates
M. Perez, J. Blankenhorn, … L. L. Parker·bioRxiv·Oct 31, 2018
- FLT3-ITD transduces autonomous growth signals during its biosynthetic trafficking in acute myelogenous leukemia cells.
K. Yamawaki, I. Shiina, … Y. Obata·bioRxiv·Jan 1, 2021